146 related articles for article (PubMed ID: 35789032)
1. Clinical characteristics of peristomal pyoderma gangrenosum: A Single Center Retrospective Observational Study.
Honma M; Sugawara M; Ueno N; Honma M; Hinooka R; Tani C
J Dermatol; 2022 Nov; 49(11):1178-1182. PubMed ID: 35789032
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Wang J; Prenner J; Wang W; Sakuraba A; Hyman N; Dalal S; Hurst R; Cohen RD; Umanskiy K; Shogan BD; Alpert L; Rubin DT; Colwell J; Pekow J
Aliment Pharmacol Ther; 2020 Jun; 51(12):1365-1372. PubMed ID: 32383278
[TBL] [Abstract][Full Text] [Related]
3. Topical Management of Peristomal Pyoderma Gangrenosum: A Report of 3 Case Studies.
Toyoda T; Mitsuyama S; Nagao E; Abe F; Kimura M; Seido Y; Higuchi T
J Wound Ostomy Continence Nurs; 2021 Jul-Aug 01; 48(4):345-349. PubMed ID: 33951706
[TBL] [Abstract][Full Text] [Related]
4. Management of peristomal pyoderma gangrenosum.
Poritz LS; Lebo MA; Bobb AD; Ardell CM; Koltun WA
J Am Coll Surg; 2008 Feb; 206(2):311-5. PubMed ID: 18222385
[TBL] [Abstract][Full Text] [Related]
5. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.
Barbosa NS; Tolkachjov SN; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT; Bridges AG; Wetter DA
J Am Acad Dermatol; 2016 Nov; 75(5):931-939. PubMed ID: 27473454
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of peristomal pyoderma gangrenosum: A systematic review.
Afifi L; Sanchez IM; Wallace MM; Braswell SF; Ortega-Loayza AG; Shinkai K
J Am Acad Dermatol; 2018 Jun; 78(6):1195-1204.e1. PubMed ID: 29288099
[TBL] [Abstract][Full Text] [Related]
7. Topical therapy for peristomal pyoderma gangrenosum.
Nybaek H; Olsen AG; Karlsmark T; Jemec GB
J Cutan Med Surg; 2004; 8(4):220-3. PubMed ID: 16091998
[TBL] [Abstract][Full Text] [Related]
8. Peristomal pyoderma gangrenosum: 12-year experience in a single tertiary referral centre.
Toh JWT; Young CJ; Rickard MJFX; Keshava A; Stewart P; Whiteley I
ANZ J Surg; 2018 Oct; 88(10):E693-E697. PubMed ID: 29984478
[TBL] [Abstract][Full Text] [Related]
9. Crushed Corticosteroid Tablets in Peristomal Pyoderma Gangrenosum: A Case Report.
Burlando M; Paravisi A; Bodini G; Cozzani E; Parodi A
J Wound Ostomy Continence Nurs; 2021 Sep-Oct 01; 48(5):460-462. PubMed ID: 34495940
[TBL] [Abstract][Full Text] [Related]
10. A novel topical therapy for resistant and early peristomal pyoderma gangrenosum.
Pearson WA; Prentice DA; Sinclair DL; Lim LY; Carville KJ
Int Wound J; 2019 Oct; 16(5):1136-1143. PubMed ID: 31298491
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and treatment of peristomal pyoderma gangrenosum.
Hughes AP; Jackson JM; Callen JP
JAMA; 2000 Sep; 284(12):1546-8. PubMed ID: 11000649
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
13. Topical tacrolimus in the management of peristomal pyoderma gangrenosum.
Lyon CC; Stapleton M; Smith AJ; Mendelsohn S; Beck MH; Griffiths CE
J Dermatolog Treat; 2001 Mar; 12(1):13-7. PubMed ID: 12171681
[TBL] [Abstract][Full Text] [Related]
14. A Case Series of 4 Patients With Peristomal Pyoderma Gangrenosum: Review of Risk Factors and Treatment Response.
Turrión-Merino L; Hermosa-Zarza E; Miguel L; Muñoz-Zato E
Actas Dermosifiliogr; 2016 Apr; 107(3):e13-7. PubMed ID: 26626501
[TBL] [Abstract][Full Text] [Related]
15. Care and treatment of peristomal gangrenous pyoderma. A study of three cases.
Julve-Herraiz L; Villalba-Ferrer F; García-Coret MJ; García-Costa B
Enferm Clin (Engl Ed); 2021; 31(2):120-125. PubMed ID: 33541774
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
[TBL] [Abstract][Full Text] [Related]
18. Twenty cases of peristomal pyoderma gangrenosum: diagnostic implications and management.
Sheldon DG; Sawchuk LL; Kozarek RA; Thirlby RC
Arch Surg; 2000 May; 135(5):564-8; discussion 568-9. PubMed ID: 10807281
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus for parastomal pyoderma gangrenosum: a report of two cases.
Altieri M; Vaziri K; Orkin BA
Ostomy Wound Manage; 2010 Sep; 56(9):56-9. PubMed ID: 20855912
[TBL] [Abstract][Full Text] [Related]
20. Treating peristomal pyoderma gangrenosum with topical crushed prednisone: a report of three cases.
DeMartyn LE; Faller NA; Miller L
Ostomy Wound Manage; 2014 Jun; 60(6):50-4. PubMed ID: 24905357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
